Nausea and vomiting · Patients with cancer receiving chemotherapy and/or radiotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · Patients with cancer receiving chemotherapy and/or radiotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective outcome measure: WBC count (× 109/L) · Patients with cancer receiving chemotherapy and/or radiotherapy
Moxibustion may leads to higher objective outcome measure: WBC count (× 109/L) compared with no treatment (low certainty).
1 finding from 1 review
Haemoglobin (g/dL) · Patients with cancer receiving chemotherapy and/or radiotherapy
Moxibustion may leads to higher objective outcome measure: haemoglobin (g/L) compared with no treatment (low certainty).
1 finding from 1 review
Objective outcome measure: platelets (× 109/L) · Patients with cancer receiving chemotherapy and/or radiotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · Patients with cancer receiving chemotherapy and/or radiotherapy
Moxibustion may leads to higher qoL (EORTC QLQ‐C30) compared with sham treatment (low certainty).
1 finding from 1 review
Insufficiency fractures and avascular necrosis · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
BMD and fracture risk · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
Bone turnover markers · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
QoL · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
All‐cause mortality · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
Adverse events · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
Reduction in oedema (T2 hyperintensity) · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Change in neurocognitive function · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe adverse events · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Quality of life · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Corticosteroid requirements · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction in post‐gadolinium enhancement · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Reduction in neurological/clinical symptoms/severity · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review
Severe adverse events · people previously treated with radiosurgery or fractionated radiotherapy to the brain or head and neck region with a diagnosis of brain…
1 finding from 1 review